Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryon A Tompkins

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Stem Cells Translational Medicine|May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection FractionAngela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 27, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging FrailtySamuel Golpanian, Darcy L DiFede, Aisha Khan, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 5, 2017
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical TrialBryon A Tompkins, Darcy L DiFede, Aisha Khan, et al.
Circulation Research|September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Stem Cells Translational Medicine|May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection FractionAngela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 27, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging FrailtySamuel Golpanian, Darcy L DiFede, Aisha Khan, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 5, 2017
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical TrialBryon A Tompkins, Darcy L DiFede, Aisha Khan, et al.
Circulation Research|September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Pageof 2